FDA Approved: MIRVASO — Supplemental Application (Galderma Laboratories, L.P.)

View source ↗

Summary

The FDA approved a supplemental application for Mirvaso (brimonidine tartrate) submitted by Galderma Laboratories, L.P., related to its labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rosacea

Drugs mentioned

• Mirvaso (brimonidine tartrate)

Snippet

SUPPL AP for MIRVASO (BRIMONIDINE TARTRATE)